Opioid peptides. Structure-activity relationships in dermorphin tetrapeptides. I

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Peptide Science

Background:

• Dermorphin, an opioid heptapeptide, serves as a reference for novel analgesic compounds.
• Synthetic peptide analogs are crucial for structure-activity relationship studies in drug discovery.

Purpose of the Study:

• To synthesize and pharmacologically evaluate twelve novel tetrapeptide analogs of dermorphin.
• To investigate the impact of specific structural modifications on opioid receptor binding and activity.

Main Methods:

• Chemical synthesis of twelve tetrapeptide analogs.
• Pharmacological assays to determine opioid receptor binding affinity and functional activity.
• Structure-activity relationship analysis based on modifications at N-terminus, Gly4, and D-Ala2 positions.

Main Results:

• N-terminal tetrapeptide amides demonstrated higher potency than their corresponding free acid or ester forms.
• Substitution of Glycine at position 4 was well-tolerated, maintaining significant activity.
• Replacement of D-Alanine at position 2 with alpha-aminoxypropionic acid resulted in a complete loss of opioid activity.
• Guanidination of the tetrapeptides led to enhanced peripheral and central opioid effects.

Conclusions:

• N-terminal amidation is critical for optimizing the opioid potency of dermorphin tetrapeptide analogs.
• The D-Alanine at position 2 is essential for maintaining opioid activity, highlighting its role in receptor interaction.
• Guanidination represents a promising strategy for augmenting the analgesic potential of these synthetic peptides.